Exelixis
EXEL
#1659
Rank
C$18.44 B
Marketcap
C$73.37
Share price
-1.01%
Change (1 day)
31.50%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company